<VariationArchive VariationID="14052" VariationName="NM_001164508.2(NEB):c.7431+1919_7536+374del" VariationType="Deletion" Accession="VCV000014052" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2013-05-03" MostRecentSubmission="2021-06-08">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="29091" VariationID="14052">
      <GeneList>
        <Gene Symbol="NEB" FullName="nebulin" GeneID="4703" HGNC_ID="HGNC:7720" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="151485339" stop="151734476" display_start="151485339" display_stop="151734476" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="152341852" stop="152591000" display_start="152341852" display_stop="152591000" Strand="-" />
          </Location>
          <OMIM>161650</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001164508.2(NEB):c.7431+1919_7536+374del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="151645756" stop="151648257" display_start="151645756" display_stop="151648257" variantLength="2502" positionVCF="151645755" referenceAlleleVCF="CTGATCCAAAATTTCATTGAGTGTCTACTATGTGTCAGGCACGATTCTAGATAAGCACTGTAGATTCAATAAGAATTGCCTCTGCCTGCAAAGAGTGCCTGTCCACACTGGGAAGAGCAATATAAGCCACCTTATGATGATATGTATAACAACGGACTGCAAGGAACAGAGAATACAGACTCCCCATTCTGCCTGACATAGTGAGTACTAACATTTCGATATTCAATCTAAAAGCCACTAAATAAGGAATCTAAGTCATATGTAGTTAATTAATTAAAATAATTCAGGGATTCAGAGAACTTCTAGACAATTTCACTGATTTAGAAACAATTAAAATGAGCTTTCTGAAAACACATGCTGAATTTGAAAACTTACATCACTTGTGTTGATTAAGTTTGCTTTAGCCAGAACAATGTCAGGTGTATCAGGCATGATGTGGATCTGAGTCTTGTCTTTGTCCCAAGCTTCTCTATAAAGTCTCTAAAATAAGAAATAATAATTTTTCAGTGGTGTTGTTAGATTAGTGAATGATACAGTTGGCTTCAAACAGAATTGCTGAATTTATCTGAATTAAACATTATACAGAATTGATATAATAAGCAGACAACATAAGCAGAAAATAGATGCAATATTTCTTGACTTATCTGGGACATAACTGCCTTTCAACACAGAGATTATGGGTCACATTTTCAAAGTTACAGATAATCCTGCCTACAAGAAATCAATCTAGGTAATTACATGCCTTGCCAATATTATCAAATGAAACAGGCTTCTCCATCTTCTGGGTTGTGTCCCTCAGTGTTTAATTTAGAGGCAGCCCTTGCCTTTTCAAAAGATGTCTTATTCAAAGCATGCCTAGAAATCAGGAAGTTTTATTTCCTATGTGGCTTATTGTTATCACTATCATTATTTTGACACAGAGTCTTACACTGCTGCCCAGGCTGGAGTGCAATGGCGCAATCATGGCTCACTGCAACCTCTGCCTCCTGAGTTCAAGTGATTCTGGTGCCTCAGCCACCTGAGTAGCTAGGATTACAGGCATGTGCCACCATACCCGGCTAATTTTTGTATTTTTAGTAGAAACAGGGTTTCGCTACGTTGTGCAGGCTGGCCTTGAACTCCCCACCTCAGCCTCCCAAAGTGCTGGGATTACAGGTGTGAGCCACTGTGTCCAGCTTCTATGTGACTTAGTATTTATAGTTATGCCTCATAATCATTGTGAAGGATTAGGATTCCCAAAAGGATTTTTTGGGGGGGAATTTATCAAGATATCTTGGATGTCCCAGAGCCATCCTTATGTCTCTTCAACAGAAGACAAGGGGATCCAAACAAAAGTTTCACAGACTTACTAAAACTAATAATTTTTTTTTTTTGAGATGGAGTTTCACTCTTGTTGCCCATGCTGGAGTGCAATGGTGCAGTCTTAGCTCACTGTAATCTCCACCTCCCAGGTTCAAGCAATTCTCCTGCCTCAGCTTCCCAAGTAGCTGGGATTACAGGCACCCACCACATGCCCAGCTAATTTTTGTATTTTTAGTAGAGATGGGGTTTCACCATGTTGGCCAGGCTGGTCTCGAACTCCTGATCGCAGGTGATCCACCTGCCTCGGCCTCCCAAAGTGCTGGGATTACAGGTGTGAGCCATCGTGCCCGGCTAAAACTAGGAAAATTTGATTAAAAACAGAATATTTACACAGGGCAGAATATCTCCCTGCCAGATTACTTATCAATTACAAAGGATAAAATGGTTACTCAACAGTACAGCAACCTGGCACCATCACTTTAACCAAGTGTTTAAGTTATTAGTAATAGAACAAATTGATATCCTGTGCCTCCTGATATGAGGTACTGAGGAGGACACAATGTGTGATCTCCTGCTGAAAAGATAATCTGAGTCTATCACAGGAACCCACCAGAAAACCCAAATGGAGGGAGATTCTACAAAATAACTGACCTATGTTCTTTACGAATGTCAAAAACTTGGAAGGCAAAGAAACAGTGAGGAACTAGTCCAGAGTAAAGGAGACTAAAGACATAGCAAGTAATGCAACCTGTGGTCTTGGATTAAATCCTGAGCCAGAGAAAATATTTTCTTTTCTTATAAAGGATATTAGTGATAAAATTGAATAAATTCTGTAGACTAGCAGACCAGTGGAAATTAATTCTGTGATTTTAATCATCACAATGTGATTATGTGAGTATGTTCTTATTCTTGGGAAATACAGACGGAATATTTAGGCATCATGAAGCAATTTAATTTCTCATATAGATATATAGATATAGATCTGAGAGAAAGAAAGGGAGAAAAAGAGACAAAAAGAGAAAGCAAATGTGGTAAAATTTTAACATTTGGGGAATCTGGGTATATGTATGCACACACACATACACACATATGTGAATTACATGTACTATTTTTTCAACTTTTCTGAGTGCCTGAAATTATTTCAATAAAAAATTTTTTTGTCTCATTGATTCCTTAAACTTGTCCATTTCCCTTTGAGGTA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="152502270" stop="152504771" display_start="152502270" display_stop="152504771" variantLength="2502" positionVCF="152502269" referenceAlleleVCF="CTGATCCAAAATTTCATTGAGTGTCTACTATGTGTCAGGCACGATTCTAGATAAGCACTGTAGATTCAATAAGAATTGCCTCTGCCTGCAAAGAGTGCCTGTCCACACTGGGAAGAGCAATATAAGCCACCTTATGATGATATGTATAACAACGGACTGCAAGGAACAGAGAATACAGACTCCCCATTCTGCCTGACATAGTGAGTACTAACATTTCGATATTCAATCTAAAAGCCACTAAATAAGGAATCTAAGTCATATGTAGTTAATTAATTAAAATAATTCAGGGATTCAGAGAACTTCTAGACAATTTCACTGATTTAGAAACAATTAAAATGAGCTTTCTGAAAACACATGCTGAATTTGAAAACTTACATCACTTGTGTTGATTAAGTTTGCTTTAGCCAGAACAATGTCAGGTGTATCAGGCATGATGTGGATCTGAGTCTTGTCTTTGTCCCAAGCTTCTCTATAAAGTCTCTAAAATAAGAAATAATAATTTTTCAGTGGTGTTGTTAGATTAGTGAATGATACAGTTGGCTTCAAACAGAATTGCTGAATTTATCTGAATTAAACATTATACAGAATTGATATAATAAGCAGACAACATAAGCAGAAAATAGATGCAATATTTCTTGACTTATCTGGGACATAACTGCCTTTCAACACAGAGATTATGGGTCACATTTTCAAAGTTACAGATAATCCTGCCTACAAGAAATCAATCTAGGTAATTACATGCCTTGCCAATATTATCAAATGAAACAGGCTTCTCCATCTTCTGGGTTGTGTCCCTCAGTGTTTAATTTAGAGGCAGCCCTTGCCTTTTCAAAAGATGTCTTATTCAAAGCATGCCTAGAAATCAGGAAGTTTTATTTCCTATGTGGCTTATTGTTATCACTATCATTATTTTGACACAGAGTCTTACACTGCTGCCCAGGCTGGAGTGCAATGGCGCAATCATGGCTCACTGCAACCTCTGCCTCCTGAGTTCAAGTGATTCTGGTGCCTCAGCCACCTGAGTAGCTAGGATTACAGGCATGTGCCACCATACCCGGCTAATTTTTGTATTTTTAGTAGAAACAGGGTTTCGCTACGTTGTGCAGGCTGGCCTTGAACTCCCCACCTCAGCCTCCCAAAGTGCTGGGATTACAGGTGTGAGCCACTGTGTCCAGCTTCTATGTGACTTAGTATTTATAGTTATGCCTCATAATCATTGTGAAGGATTAGGATTCCCAAAAGGATTTTTTGGGGGGGAATTTATCAAGATATCTTGGATGTCCCAGAGCCATCCTTATGTCTCTTCAACAGAAGACAAGGGGATCCAAACAAAAGTTTCACAGACTTACTAAAACTAATAATTTTTTTTTTTTGAGATGGAGTTTCACTCTTGTTGCCCATGCTGGAGTGCAATGGTGCAGTCTTAGCTCACTGTAATCTCCACCTCCCAGGTTCAAGCAATTCTCCTGCCTCAGCTTCCCAAGTAGCTGGGATTACAGGCACCCACCACATGCCCAGCTAATTTTTGTATTTTTAGTAGAGATGGGGTTTCACCATGTTGGCCAGGCTGGTCTCGAACTCCTGATCGCAGGTGATCCACCTGCCTCGGCCTCCCAAAGTGCTGGGATTACAGGTGTGAGCCATCGTGCCCGGCTAAAACTAGGAAAATTTGATTAAAAACAGAATATTTACACAGGGCAGAATATCTCCCTGCCAGATTACTTATCAATTACAAAGGATAAAATGGTTACTCAACAGTACAGCAACCTGGCACCATCACTTTAACCAAGTGTTTAAGTTATTAGTAATAGAACAAATTGATATCCTGTGCCTCCTGATATGAGGTACTGAGGAGGACACAATGTGTGATCTCCTGCTGAAAAGATAATCTGAGTCTATCACAGGAACCCACCAGAAAACCCAAATGGAGGGAGATTCTACAAAATAACTGACCTATGTTCTTTACGAATGTCAAAAACTTGGAAGGCAAAGAAACAGTGAGGAACTAGTCCAGAGTAAAGGAGACTAAAGACATAGCAAGTAATGCAACCTGTGGTCTTGGATTAAATCCTGAGCCAGAGAAAATATTTTCTTTTCTTATAAAGGATATTAGTGATAAAATTGAATAAATTCTGTAGACTAGCAGACCAGTGGAAATTAATTCTGTGATTTTAATCATCACAATGTGATTATGTGAGTATGTTCTTATTCTTGGGAAATACAGACGGAATATTTAGGCATCATGAAGCAATTTAATTTCTCATATAGATATATAGATATAGATCTGAGAGAAAGAAAGGGAGAAAAAGAGACAAAAAGAGAAAGCAAATGTGGTAAAATTTTAACATTTGGGGAATCTGGGTATATGTATGCACACACACATACACACATATGTGAATTACATGTACTATTTTTTCAACTTTTCTGAGTGCCTGAAATTATTTCAATAAAAAATTTTTTTGTCTCATTGATTCCTTAAACTTGTCCATTTCCCTTTGAGGTA" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>R2478_D2512del</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009382.2" sequenceAccession="NG_009382" sequenceVersion="2" change="g.91229_93730del">
            <Expression>NG_009382.2:g.91229_93730del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="protein">
          <ProteinExpression sequenceAccessionVersion="NP_004534?.2" sequenceAccession="NP_004534?" sequenceVersion="2" change="p.Arg2478_Asp2512del">
            <Expression>NP_004534?.2:p.Arg2478_Asp2512del</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004543.3" sequenceAccession="NM_004543" sequenceVersion="3" change="c.7622-2025_7727+372del2502">
            <Expression>NM_004543.3:c.7622-2025_7727+372del2502</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.152502272_152504773del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.152502272_152504773del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.151645758_151648259del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.151645758_151648259del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009382.2" sequenceAccession="NG_009382" sequenceVersion="2" change="g.91231_93732del">
            <Expression>NG_009382.2:g.91231_93732del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004543.5" sequenceAccession="NM_004543" sequenceVersion="5" change="c.7431+1919_7536+374del">
            <Expression>NM_004543.5:c.7431+1919_7536+374del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164508.2" sequenceAccession="NM_001164508" sequenceVersion="2" change="c.7431+1919_7536+374del" MANESelect="true">
            <Expression>NM_001164508.2:c.7431+1919_7536+374del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164507.2" sequenceAccession="NM_001164507" sequenceVersion="2" change="c.7431+1919_7536+374del" MANEPlusClinical="true">
            <Expression>NM_001164507.2:c.7431+1919_7536+374del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271208.2" sequenceAccession="NM_001271208" sequenceVersion="2" change="c.7431+1919_7536+374del">
            <Expression>NM_001271208.2:c.7431+1919_7536+374del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_202" sequenceAccession="LRG_202">
            <Expression>LRG_202:g.91231_93732del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004543.4" sequenceAccession="NM_004543" sequenceVersion="4" change="c.7432-2025_7536+372del">
            <Expression>NM_004543.4:c.7432-2025_7536+372del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="NEB_000007" DB="LOVD 3" />
        <XRef ID="nssv3761583" DB="dbVar" />
        <XRef ID="nsv1067832" DB="dbVar" />
        <XRef Type="Allelic variant" ID="161650.0007" DB="OMIM" />
        <XRef ID="CA341320" DB="ClinGen" />
        <XRef ID="GTR000575392" DB="Genetic Testing Registry (GTR)" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001164508.2(NEB):c.7431+1919_7536+374del AND Nemaline myopathy 2" Accession="RCV000015096" Version="36">
        <ClassifiedConditionList TraitSetID="3882">
          <ClassifiedCondition DB="MedGen" ID="C1850569">Nemaline myopathy 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-03-15" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001164508.2(NEB):c.7431+1919_7536+374del AND Arthrogryposis multiplex congenita 6" Accession="RCV001449896" Version="9">
        <ClassifiedConditionList TraitSetID="66961">
          <ClassifiedCondition DB="MedGen" ID="C5543431">Arthrogryposis multiplex congenita 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2009-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2012-03-15" NumberOfSubmissions="3" NumberOfSubmitters="2" DateCreated="2013-05-03" MostRecentSubmission="2021-06-08">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15221447</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19232495</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19346529</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22367672</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27933661</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301465</ID>
          <ID Source="BookShelf">NBK1288</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="66961" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="56163" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Arthrogryposis multiplex congenita 6</ElementValue>
                <XRef ID="MONDO:0030281" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AMC6</ElementValue>
                <XRef Type="MIM" ID="619334" DB="OMIM" />
              </Symbol>
              <XRef ID="C5543431" DB="MedGen" />
              <XRef ID="MONDO:0030281" DB="MONDO" />
              <XRef Type="MIM" ID="619334" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3882" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5618" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nemaline myopathy caused by mutation in the nebulin gene</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nemaline myopathy 2</ElementValue>
                <XRef ID="Nemaline+myopathy+2/5124" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009725" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nemaline myopathy 2, autosomal recessive</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NEM2</ElementValue>
                <XRef Type="MIM" ID="256030" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15209" />
                <XRef ID="15209" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2012">
                <ID Source="PubMed">22510848</ID>
              </Citation>
              <XRef ID="C1850569" DB="MedGen" />
              <XRef ID="MONDO:0009725" DB="MONDO" />
              <XRef Type="MIM" ID="256030" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="41104" SubmissionDate="2013-04-30" DateLastUpdated="2013-05-03" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_004543.3:c.7622-2025_7727+372del2502_NBK1288" title="NM_004543.3:c.7622-2025_7727+372del2502 and Nemaline Myopathy" />
        <ClinVarAccession Accession="SCV000041104" DateUpdated="2013-05-03" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-03-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>pathologic</GermlineClassification>
          <Comment>Converted during submission to Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004543.3:c.7622-2025_7727+372del2502</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Nemaline Myopathy</ElementValue>
            </Name>
            <XRef DB="GeneReviews" ID="NBK1288" />
            <XRef DB="OMIM" ID="256030" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="35353" SubmissionDate="2021-05-27" DateLastUpdated="2018-04-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="161650.0007_NEMALINE MYOPATHY 2" title="NEB, 2,502-BP DEL, EX55 DEL_NEMALINE MYOPATHY 2" />
        <ClinVarAccession Accession="SCV000035353" DateUpdated="2018-04-09" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Nemaline Myopathy 2</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 5 affected individuals from 5 Ashkenazi Jewish families with autosomal recessive typical nemaline myopathy (NEM2; 256030), Anderson et al. (2004) identified a homozygosity for a 2,502-bp deletion completely encompassing exon 55 and parts of introns 54 and 55 of the NEB gene, predicted to result in a transcript encoding 35 fewer amino acids. Screening for this mutation in a random sample of 4,090 Ashkenazi Jewish individuals revealed a carrier frequency of 1 in 108.</Attribute>
              <Citation>
                <ID Source="PubMed">15221447</ID>
              </Citation>
              <XRef DB="OMIM" ID="256030" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Lehtokari et al. (2009) identified the 2,502-bp deletion in 14 of 355 probands with nemaline myopathy from around the world; 2 of the probands had been reported by Anderson et al. (2004). Seven probands were homozygous for the deletion, and 7 carried the mutation in heterozygosity. Two of the families were not of known Ashkenazi Jewish descent, but carried the common haplotype identified in Ashkenazi Jews. The findings were consistent with a founder effect.</Attribute>
              <Citation>
                <ID Source="PubMed">19232495</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">15221447</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Ottenheijm et al. (2009) studied the muscular phenotype of nemaline myopathy patients with NEB exon 55 deletion (NM-NEB). SDS-PAGE and Western blot analysis revealed greatly reduced nebulin levels in skeletal muscle of NM-NEB patients, with the most prominent reduction at nebulin's N-terminal end. Muscle mechanical studies indicated an approximately 60% reduced force generating capacity of NM-NEB muscle and a leftward shift of the force-sarcomere length relation in NM-NEB muscle fibers. This indicates that the mechanism for the force reduction is likely to include shorter and nonuniform thin filament lengths in NM-NEB muscle compared with control muscle. The average thin filament length was reduced from approximately 1.3-micrometer in control muscle to approximately 0.75-micrometer in NM-NEB muscle. Ottenheijm et al. (2009) hypothesized that dysregulated thin filament length may contribute to muscle weakness in nemaline myopathy patients with nebulin mutations.</Attribute>
              <Citation>
                <ID Source="PubMed">19346529</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Arthrogryposis Multiplex Congenita 6</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Yonath et al. (2012) reported 4 unrelated pregnancies with abnormal prenatal ultrasound findings in fetuses with arthrogryposis multiplex congenita-6 (AMC6; 619334). In each family, 1 or both of the parents was of Ashkenazi Jewish descent, and the common exon 55 deletion in the NEB gene was found in the heterozygous state in the patients and in unaffected parents. A second pathogenic NEB mutation was found in 3 of the patients; a second mutation could not be identified in 1 of the patients. Prenatal ultrasound showed polyhydramnios, decreased fetal movements, clubfoot, and clenched hands. All patients showed severe hypotonia after birth, and all died within the first months of life.</Attribute>
              <Citation>
                <ID Source="PubMed">22367672</ID>
              </Citation>
              <XRef DB="OMIM" ID="619334" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Feingold-Zadok et al. (2017) identified this mutation in 2 fetal sibs with AMC6 from an Ashkenazi Jewish family (family 1), in compound heterozygosity with a splice site mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">27933661</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NEB" />
          </GeneList>
          <Name>NEB, 2,502-BP DEL, EX55 DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2,502-BP DEL, EX55 DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="161650.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEMALINE MYOPATHY 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3255939" SubmissionDate="2021-05-27" DateLastUpdated="2021-06-08" DateCreated="2021-06-08">
        <ClinVarSubmissionID localKey="161650.0007_ARTHROGRYPOSIS MULTIPLEX CONGENITA 6" title="NEB, 2,502-BP DEL, EX55 DEL_ARTHROGRYPOSIS MULTIPLEX CONGENITA 6" />
        <ClinVarAccession Accession="SCV001653292" DateUpdated="2021-06-08" DateCreated="2021-06-08" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Nemaline Myopathy 2</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 5 affected individuals from 5 Ashkenazi Jewish families with autosomal recessive typical nemaline myopathy (NEM2; 256030), Anderson et al. (2004) identified a homozygosity for a 2,502-bp deletion completely encompassing exon 55 and parts of introns 54 and 55 of the NEB gene, predicted to result in a transcript encoding 35 fewer amino acids. Screening for this mutation in a random sample of 4,090 Ashkenazi Jewish individuals revealed a carrier frequency of 1 in 108.</Attribute>
              <Citation>
                <ID Source="PubMed">15221447</ID>
              </Citation>
              <XRef DB="OMIM" ID="256030" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Lehtokari et al. (2009) identified the 2,502-bp deletion in 14 of 355 probands with nemaline myopathy from around the world; 2 of the probands had been reported by Anderson et al. (2004). Seven probands were homozygous for the deletion, and 7 carried the mutation in heterozygosity. Two of the families were not of known Ashkenazi Jewish descent, but carried the common haplotype identified in Ashkenazi Jews. The findings were consistent with a founder effect.</Attribute>
              <Citation>
                <ID Source="PubMed">19232495</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">15221447</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Ottenheijm et al. (2009) studied the muscular phenotype of nemaline myopathy patients with NEB exon 55 deletion (NM-NEB). SDS-PAGE and Western blot analysis revealed greatly reduced nebulin levels in skeletal muscle of NM-NEB patients, with the most prominent reduction at nebulin's N-terminal end. Muscle mechanical studies indicated an approximately 60% reduced force generating capacity of NM-NEB muscle and a leftward shift of the force-sarcomere length relation in NM-NEB muscle fibers. This indicates that the mechanism for the force reduction is likely to include shorter and nonuniform thin filament lengths in NM-NEB muscle compared with control muscle. The average thin filament length was reduced from approximately 1.3-micrometer in control muscle to approximately 0.75-micrometer in NM-NEB muscle. Ottenheijm et al. (2009) hypothesized that dysregulated thin filament length may contribute to muscle weakness in nemaline myopathy patients with nebulin mutations.</Attribute>
              <Citation>
                <ID Source="PubMed">19346529</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Arthrogryposis Multiplex Congenita 6</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Yonath et al. (2012) reported 4 unrelated pregnancies with abnormal prenatal ultrasound findings in fetuses with arthrogryposis multiplex congenita-6 (AMC6; 619334). In each family, 1 or both of the parents was of Ashkenazi Jewish descent, and the common exon 55 deletion in the NEB gene was found in the heterozygous state in the patients and in unaffected parents. A second pathogenic NEB mutation was found in 3 of the patients; a second mutation could not be identified in 1 of the patients. Prenatal ultrasound showed polyhydramnios, decreased fetal movements, clubfoot, and clenched hands. All patients showed severe hypotonia after birth, and all died within the first months of life.</Attribute>
              <Citation>
                <ID Source="PubMed">22367672</ID>
              </Citation>
              <XRef DB="OMIM" ID="619334" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Feingold-Zadok et al. (2017) identified this mutation in 2 fetal sibs with AMC6 from an Ashkenazi Jewish family (family 1), in compound heterozygosity with a splice site mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">27933661</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NEB" />
          </GeneList>
          <Name>NEB, 2,502-BP DEL, EX55 DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2,502-BP DEL, EX55 DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="161650.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">ARTHROGRYPOSIS MULTIPLEX CONGENITA 6</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3255939" TraitType="Disease" MappingType="Name" MappingValue="ARTHROGRYPOSIS MULTIPLEX CONGENITA 6" MappingRef="Alternate">
        <MedGen CUI="C5543431" Name="Arthrogryposis multiplex congenita 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="35353" TraitType="Disease" MappingType="Name" MappingValue="NEMALINE MYOPATHY 2" MappingRef="Preferred">
        <MedGen CUI="C1850569" Name="Nemaline myopathy 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="41104" TraitType="Disease" MappingType="Name" MappingValue="Nemaline Myopathy" MappingRef="Preferred">
        <MedGen CUI="C0206157" Name="Nemaline myopathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>